Cargando…
Ginsenoside Rg1 Improves Inflammation and Autophagy of the Pancreas and Spleen in Streptozotocin-Induced Type 1 Diabetic Mice
BACKGROUND: Ginsenoside Rg1 (Rg1) is one of the key bioactive components of the precious Traditional Chinese Medicine that has been used to treat diabetes in China. Ginsenosides have been reported to protect diabetics from tissue damage, inflammation, and insulin resistance. Type 1 diabetes (T1D) is...
Autores principales: | Zong, Yi, Yu, Weihua, Hong, Hanghang, Zhu, Zhiqiang, Xiao, Wenbo, Wang, Kewu, Xu, Guoqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030220/ https://www.ncbi.nlm.nih.gov/pubmed/36960388 http://dx.doi.org/10.1155/2023/3595992 |
Ejemplares similares
-
Ginsenoside Rg1 Ameliorates Pancreatic Injuries via the AMPK/mTOR Pathway in vivo and in vitro
por: Chen, Jin, et al.
Publicado: (2023) -
Ginsenoside Rg1 ameliorates cardiac oxidative stress and inflammation in streptozotocin-induced diabetic rats
por: Qin, Qiaoji, et al.
Publicado: (2019) -
Ginsenoside Rg1 improves bone marrow haematopoietic activity via extramedullary haematopoiesis of the spleen
por: Liu, Hua-Hsing, et al.
Publicado: (2015) -
The protective effect of Ginsenoside Rg1 on aging mouse pancreas damage induced by D-galactose
por: Dong, Zhaoying, et al.
Publicado: (2017) -
Upregulation of autophagy by Ginsenoside Rg2 in MCF-7 cells
por: Chung, Yuheon, et al.
Publicado: (2018)